Bayer AG
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- Germany
- Registered address
- Friedrich-Ebert-Str. 217-333, Wuppertal, 42117, Germany (DEU)
- Operations here
- analysisapi manufacturepack
- FDA identifiers
- FEI 3003229486 · DUNS 323208116
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2023-01-18
- NAIDrug Quality Assurance2018-06-29
- NAIDrug Quality Assurance2015-04-30
- NAIDrug Quality Assurance2012-12-06
- VAIBioresearch Monitoring2010-05-27
- NAIDrug Quality Assurance2010-02-05
- NAIDrug Quality Assurance2009-05-26
Drugs this plant is listed as making
8 distinct drugs across 12 products name this site in their FDA label.
- ciprofloxacinBayer HealthCare Pharmaceuticals Inc.
- ciprofloxacin hydrochlorideBayer HealthCare Pharmaceuticals Inc.
- finerenoneBayer HealthCare Pharmaceuticals Inc.
- regorafenibBayer HealthCare Pharmaceuticals Inc.
- rivaroxabanJanssen Pharmaceuticals, Inc.
- SevabertinibBayer HealthCare Pharmaceuticals Inc.
- sorafenibBayer HealthCare Pharmaceuticals Inc.
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.